Search In this Thesis
   Search In this Thesis  
العنوان
Effect of Single Anastomosis Duodeno-ileal Bypass (SADI) on Type 2 Diabetes Mellitus /
المؤلف
Abdelgawad, Moataz Taha Gomaa.
هيئة الاعداد
باحث / Moataz Taha Gomaa Abdelgawad
مشرف / Ahmad Helmy Ali Youssuf
مشرف / Islam Hossam El-Din El-Abbassy
مناقش / Mohamed Gamal El-Fouly
تاريخ النشر
2019
عدد الصفحات
133p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
جراحة
تاريخ الإجازة
1/1/2019
مكان الإجازة
جامعة عين شمس - كلية الطب - جراحة عامة
الفهرس
Only 14 pages are availabe for public view

from 133

from 133

Abstract

Type 2 D.M. together is becoming a worldwide challenge, as well as obesity. Conventional therapy and life-style changing measures are not enough for many patients to face the long-term consequences of such morbidities, hence the development of various metabolic surgeries evolved as an alternative in patients who do not benefit enough from the non-surgical measures.
Surgeries fell into three main categories: Restrictive (e.g. Sleeve Gastrectomy), Largely restrictive mildly malabsorptive (e.g. Reux en Y gastric bypass) and Largely malabsorptive mildly restrictrive (e.g. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy).
Concerning SADI-S; since it combines both restrictive and malabsorptive patients it proved to be providing the patients with long-term solution for both their obesity and metabolic diseases. Although it can not be described as a simple procedure or a first choice in every patient, it still provides lots of patients a satisfactory revisional procedure for failing primary ones, as well as a rational first choice tailored for patients whose life-style and morbidity history make them good candidates for such a procedure, as long as trained surgical hands are available, done either in one step or two.
Its superiority as procedure over many other bariatric and metabolic surgeries had been proven, and our meta-analysis here gives supports it as a highly effective procedure in the face of type 2 diabetes with very satisfactory outcomes in terms of postoperative glycemic control and need for medication.